Publication | Closed Access
FOLFIRINOX for Advanced Pancreatic Cancer Patients After Nab-Paclitaxel Plus Gemcitabine Failure
18
Citations
17
References
2020
Year
FOLFIRINOX has potential activity for patients with APC in whom GP failed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1